We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current EKSO market cap is 19.34M. The company's latest EPS is USD -0.8489 and P/E is -1.26.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 3.55M | 4.12M | 4.7M | 4.61M | 4.85M |
Operating Income | -4.44M | -4.45M | -4.28M | -2.93M | -3.45M |
Net Income | -3.18M | -4.39M | -4.23M | -3.37M | -3.21M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 13.92M | 8.88M | 11.25M | 12.91M | 18.28M |
Operating Income | -16.64M | -13.29M | -14.71M | -15.56M | -15.11M |
Net Income | -12.13M | -15.83M | -9.76M | -15.08M | -15.2M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 40.9M | 37.1M | 33.99M | 31.18M | 28.92M |
Total Liabilities | 15.46M | 15.82M | 16.18M | 15.93M | 16.31M |
Total Equity | 25.44M | 21.28M | 17.81M | 15.26M | 12.61M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 21.92M | 20.6M | 49.17M | 40.9M | 28.92M |
Total Liabilities | 15.12M | 16.16M | 11.95M | 15.46M | 16.31M |
Total Equity | 6.8M | 4.43M | 37.22M | 25.44M | 12.61M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -14.69M | -4.21M | -7.12M | -10.47M | -15.72M |
Investing | -5.18M | -42k | -97k | -114k | -157k |
Financing | N/A | N/A | N/A | N/A | 348k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -15.77M | -8.76M | -11.16M | -14.69M | -15.72M |
Investing | -60k | N/A | -59k | -5.18M | -157k |
Financing | 19.04M | 10.7M | 38.71M | N/A | 348k |
Market Cap | 19.34M |
Price to Earnings Ratio | -1.26 |
Price to Sales Ratio | 1.05 |
Price to Cash Ratio | 2.89 |
Price to Book Ratio | 1.52 |
Dividend Yield | - |
Shares Outstanding | 17.9M |
Average Volume (1 week) | 55.77k |
Average Volume (1 Month) | 56.84k |
52 Week Change | -21.17% |
52 Week High | 3.1285 |
52 Week Low | 0.62 |
Spread (Intraday) | 0.02 (1.85%) |
Company Name | Ekso Bionics Holdings Inc |
Address |
8275 south eastern avenue las vegas, nevada 89123 |
Website | https://www.eksobionics.com |
Industry | general indl mach & eq, nec (3569) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions